Evaluation of the Antiplatelet Effects of Cilostazol, a Phosphodiesterase 3 Inhibitor, by VASP Phosphorylation and Platelet Aggregation

Hiromi Yamamoto, Kanako Takahashi, Haruyo Watanabe, Yuka Yoshikawa, Ryutaro Shirakawa, Tomohito Higashi, Mitsunori Kawato, Tomoyuki Ikeda, Arata Tabuchi, Takeshi Morimoto,

Circulation Journal · 2008 · 26 citations · 24 references

DOIFull text

Open access

Abstract

The antiplatelet effects of cilostazol intake could be evaluated by measuring VASP phosphorylation levels and maximal aggregation rates in platelets by ex vivo treatment with a low concentration of PGE(1).

References

24